A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic Urticaria
Clinical trial NCT04548869 · COMPLETED
Trial details
- NCT number
- NCT04548869
- Sponsor
- Celldex Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-24
- Primary completion
- 2022-12-16
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.